U.S. Contraceptives Market size to cross USD 13.5 Billion by 2034

Selbyville, DE. - U.S. contraceptives market was estimated at USD 7.3 billion in 2024 and is expected to grow from USD 7.6 billion in 2025 to USD 13.5 billion by 2034, at a CAGR of 6.6%, according to the latest report published by Global Market Insights Inc.  

Public health campaigns and educational programs have significantly increased awareness about the importance of birth control and reproductive autonomy, leading to greater adoption of contraceptives across age groups.

Key Insights:

Market Size & Growth:

• 2024 Market Size: USD 7.3 billion  
• 2025 Market Size: USD 7.6 billion  
• 2034 Forecast Market Size: USD 13.5 billion  
• CAGR (2025–2034): 6.6%  

Regional Insights:

• Largest Market: South Atlantic  
• Fastest Growing Market: West South Centra  

Key Growth Drivers:

1. Growing female workforce participation: As more women delay childbearing in favor of career advancement and education, the demand for reliable contraceptive methods, long-acting reversible contraceptives (LARCs), has seen a noticeable uptick.  
2. Availability of a wide range of contraceptive options: The U.S. market offers diverse options, including oral pills, intrauterine devices (IUDs), injectables, implants, condoms, and emergency contraceptives, allowing users to choose based on their lifestyle, health needs, and preferences.  
3. Supportive government and NGO initiatives: Programs like Title X and coverage under the Affordable Care Act have expanded access to contraception, particularly for low-income and underserved populations, driving consistent demand across various demographics.  
4. Increased focus on Women’s health and preventive care: Greater attention on women's wellness, by the healthcare industry and through media, has encouraged regular gynecological visits, where contraceptive counseling and prescriptions are often initiated.  
5. Technological advancements and digital access: Telehealth services and digital health platforms have made it easier for individuals to consult healthcare providers, receive prescriptions, and order contraceptives online.  

Key Players:

• Bayer is leading the market with over 19.5% share in 2024.  
• Some of the top players in this market include Atlas Copco, Generac Power Systems, HIMOINSA, Caterpillar, and Cummins, which together held a 65.1% share in 2024.  

Key Challenges:

1. Political and regulatory uncertainty: Changes in reproductive health policies, including access restrictions at the state level and potential rollbacks on federal protections, create an unstable environment for both consumers and contraceptive providers.  
2. Stigma and cultural barriers: Despite growing awareness, social stigma and conservative attitudes around contraception still exist in some communities, limiting open conversations and discouraging use, particularly among teens and unmarried women.  
3. Unequal access across demographics: Low-income, rural, and minority populations often face barriers in accessing contraceptive services due to a lack of nearby clinics, transportation issues, or limited insurance coverage.  
4. Side effects and health concerns: Hormonal contraceptives can cause side effects such as mood changes, weight gain, and increased risk of certain conditions, leading some users to discontinue use or avoid hormonal methods altogether.  
5. Limited male contraceptive options: The market is overwhelmingly female-focused, with very few effective and reversible contraceptive options available for men  

Browse key industry insights spread across 120 pages with 103 market data tables and figures from the report, “U.S. Contraceptives Market - By Product, By Age Group, By Distribution Channel - Forecast, 2025 - 2034” in detail, along with the table of contents:  

https://www.gminsights.com/industry-analysis/us-contraceptives-market  

Devices to Gain Traction

The devices segment held a significant share in 2024, driven largely by the growing preference for long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and contraceptive implants. These methods offer years of protection with minimal user intervention, making them ideal for individuals seeking low-maintenance and highly effective birth control. Healthcare providers recommend device-based options over daily-use products.  

Rising Prevalence Among 15–44 Years

The individuals aged 15 to 44 segment held sustainable growth in 2024, driven by most of the demand across both prescription and over-the-counter categories. This age group encompasses teens, young adults, and women in their reproductive prime, making it a key focus for public health campaigns and commercial marketing efforts alike.  

Increasing Demand in Retail Pharmacies

The retail pharmacies segment held a notable share in 2024, backed by offering consumers convenient access to prescription and over-the-counter products. Chains like CVS, Walgreens, and independent stores serve as primary points of sale for birth control pills, condoms, emergency contraceptives, and even telehealth-related fulfillment. In-store education campaigns, loyalty programs, and discreet purchasing options continue to make pharmacies a trusted channel for contraceptive access.  

Regional Insights

South Atlantic to Emerge as a Lucrative Region

South Atlantic contraceptives market held a sustainable share in 2024, driven by a combination of rising population density, urbanization, and expanded access to reproductive health services. Although the region faces ongoing disparities in care access particularly in rural areas, telehealth expansion and mobile clinics are helping bridge gaps. Ongoing public health initiatives and targeted education efforts are also helping normalize contraceptive use across diverse communities.  

Major players in the U.S. Contraceptives Market are Evofem Biosciences, Reckitt, Mayer Laboratories, Perrigo Company, Johnson & Johnson, Organon, Pregna International, Church & Dwight, LifeStyles Healthcare, Agile Therapeutics, CooperSurgical, Pfizer, Meril Life Sciences, Bayer, and HRA Pharma.  

Companies in the U.S. contraceptives market are strengthening their foothold through a blend of product innovation, targeted awareness campaigns, and expanded distribution channels. Many are investing in the development of hormone-free alternatives, biodegradable condoms, and extended-release devices to meet evolving consumer preferences. Strategic partnerships with telehealth platforms and pharmacy chains are also helping brands reach customers more directly and discreetly. Additionally, companies are leveraging data analytics to personalize marketing, focusing on segments such as first-time users, post-partum women, and college students.